Regulatory T cells selectively preserve immune privilege of self-antigens during viral central nervous system infection

Journal of Immunology

Volumn 188, Issue 8, 2012, Pages 3678-3685

  Cervantes Barragán, Luisa ^a   Firner, Sonja ^a   Bechmann, Ingo ^b   Waisman, Ari ^c   Lahl, Katharina ^d   Sparwasser, Tim ^e   Thiel, Volker ^a,f   Ludewig, Burkhard ^a,f  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR3; DIPHTHERIA TOXIN; TRANSCRIPTION FACTOR FOXP3;

ACUTE VIRAL ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD4+ FOXP3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL SPECIFICITY; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; DISEASE SEVERITY; HEPATITIS VIRUS; IMMUNOREGULATION; IN VIVO STUDY; LYMPHATIC DRAINAGE; LYMPHOCYTE PROLIFERATION; MOUSE; NERVE CELL LESION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; VIRAL CLEARANCE; VIRUS INFECTION; VIRUS STRAIN;

ACUTE DISEASE; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, CD4; AUTOANTIGENS; AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM INFECTIONS; CORONAVIRUS INFECTIONS; ENCEPHALOMYELITIS; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNITY, CELLULAR; LYMPH NODES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MURINE HEPATITIS VIRUS; RECEPTORS, CXCR3; T-LYMPHOCYTES, REGULATORY;

EID: 84860327199     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1102422     Document Type: Article

References (46)

1. Gilden, D. H. 2005. Infectious causes of multiple sclerosis. Lancet Neurol. 4: 195-202. (Pubitemid 40269150)
2. Münz, C., J. D. Lünemann, M. T. Getts, and S. D. Miller. 2009. Antiviral immune responses: triggers of or triggered by autoimmunity? Nat. Rev. Immunol. 9:246-258.
3. Levin, L. I., K. L. Munger, E. J. O'Reilly, K. I. Falk, and A. Ascherio. 2010. Primary infection with the Epstein-Barr virus and risk of multiple sclerosis. Ann. Neurol. 67: 824-830.
4. Soldan, S. S., R. Berti, N. Salem, P. Secchiero, L. Flamand, P. A. Calabresi, M. B. Brennan, H. W. Maloni, H. F. McFarland, H. C. Lin, et al. 1997. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat. Med. 3: 1394-1397. (Pubitemid 28011041)
5. Arbour, N., R. Day, J. Newcombe, and P. J. Talbot. 2000. Neuroinvasion by human respiratory coronaviruses. J. Virol. 74: 8913-8921.
6. Stewart, J. N., S. Mounir, and P. J. Talbot. 1992. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology 191: 502-505.
7. Lünemann, J. D., N. Edwards, P. A. Muraro, S. Hayashi, J. I. Cohen, C. Münz, and R. Martin. 2006. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 129: 1493-1506. (Pubitemid 43999382)
8. Boucher, A., M. Desforges, P. Duquette, and P. J. Talbot. 2007. Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients. Clin. Immunol. 123: 258-267. (Pubitemid 46830769)
9. Miller, S. D., C. L. Vanderlugt, W. S. Begolka, W. Pao, R. L. Yauch, K. L. Neville, Y. Katz-Levy, A. Carrizosa, and B. S. Kim. 1997. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3: 1133-1136. (Pubitemid 27444456)
10. Galea, I., I. Bechmann, and V. H. Perry. 2007. What is immune privilege (not)? Trends Immunol. 28: 12-18. (Pubitemid 44960159)
11. Bour-Jordan, H., J. H. Esensten, M. Martinez-Llordella, C. Penaranda, M. Stumpf, and J. A. Bluestone. 2011. Intrinsic and extrinsic control of peripheral T-cell tolerance by costimulatory molecules of the CD28/B7 family. Immunol. Rev. 241: 180-205.
12. Vitale, G., F. Mion, and C. Pucillo. 2010. Regulatory B cells: evidence, developmental origin and population diversity. Mol. Immunol. 48: 1-8.
13. Wing, K., and S. Sakaguchi. 2010. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11: 7-13.
14. Vignali, D. A., L. W. Collison, and C. J. Workman. 2008. How regulatory T cells work. Nat. Rev. Immunol. 8: 523-532.
15. Zheng, Y., and A. Y. Rudensky. 2007. Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8: 457-462. (Pubitemid 46605910)
16. Shevach, E. M. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.
17. Venken, K., N. Hellings, R. Liblau, and P. Stinissen. 2010. Disturbed regulatory T cell homeostasis in multiple sclerosis. Trends Mol. Med. 16: 58-68.
18. Cobbold, S. P., E. Adams, L. Graca, S. Daley, S. Yates, A. Paterson, N. J. Robertson, K. F. Nolan, P. J. Fairchild, and H. Waldmann. 2006. Immune privilege induced by regulatory T cells in transplantation tolerance. Immunol. Rev. 213: 239-255. (Pubitemid 44401505)
19. Lund, J. M., L. Hsing, T. T. Pham, and A. Y. Rudensky. 2008. Coordination of early protective immunity to viral infection by regulatory T cells. Science 320: 1220-1224. (Pubitemid 351929511)
20. Fulton, R. B., D. K. Meyerholz, and S. M. Varga. 2010. Foxp3+ CD4 regulatory T cells limit pulmonary immunopathology by modulating the CD8 T cell response during respiratory syncytial virus infection. J. Immunol. 185: 2382-2392.
21. Zelinskyy, G., K. Dietze, T. Sparwasser, and U. Dittmer. 2009. Regulatory T cells suppress antiviral immune responses and increase viral loads during acute infection with a lymphotropic retrovirus. PLoS Pathog. 5: e1000406.
22. Zelinskyy, G., K. K. Dietze, Y. P. Hüsecken, S. Schimmer, S. Nair, T. Werner, K. Gibbert, O. Kershaw, A. D. Gruber, T. Sparwasser, and U. Dittmer. 2009. The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response. Blood 114: 3199-3207.
23. Bergmann, C. C., T. E. Lane, and S. A. Stohlman. 2006. Coronavirus infection of the central nervous system: host-virus stand-off. Nat. Rev. Microbiol. 4: 121-132. (Pubitemid 43158155)
24. Lahl, K., C. Loddenkemper, C. Drouin, J. Freyer, J. Arnason, G. Eberl, A. Hamann, H. Wagner, J. Huehn, and T. Sparwasser. 2007. Selective depletion of Foxp3+ regulatory T cells induces a scurfy-like disease. J. Exp. Med. 204: 57-63. (Pubitemid 46148756)
25. Bettelli, E., M. Pagany, H. L. Weiner, C. Linington, R. A. Sobel, and V. K. Kuchroo. 2003. Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J. Exp. Med. 197: 1073-1081. (Pubitemid 36570063)
26. Cervantes-Barragán, L., U. Kalinke, R. Züst, M. König, B. Reizis, C. López-Macías, V. Thiel, and B. Ludewig. 2009. Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J. Immunol. 182: 1099-1106.
27. Züst, R., L. Cervantes-Barragan, T. Kuri, G. Blakqori, F. Weber, B. Ludewig, and V. Thiel. 2007. Identification of coronavirus non-structural protein 1 as a major pathogenicity factor-implications for the rational design of live attenuated coronavirus vaccines. PLoS Pathog. 3: e109.
28. Bechmann, I., I. Galea, and V. H. Perry. 2007. What is the blood-brain barrier (not)? Trends Immunol. 28: 5-11. (Pubitemid 46001619)
29. Castro, R. F., and S. Perlman. 1996. Differential antigen recognition by T cells from the spleen and central nervous system of coronavirus-infected mice. Virology 222: 247-251. (Pubitemid 26281376)
30. Xue, S., A. Jaszewski, and S. Perlman. 1995. Identification of a CD4+ T cell epitope within the M protein of a neurotropic coronavirus. Virology 208: 173-179.
31. Godfrey, V. L., J. E. Wilkinson, and L. B. Russell. 1991. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 138: 1379-1387.
32. Cervantes-Barragan, L., R. Züst, F. Weber, M. Spiegel, K. S. Lang, S. Akira, V. Thiel, and B. Ludewig. 2007. Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood 109: 1131-1137. (Pubitemid 46220660)
33. Reboldi, A., C. Coisne, D. Baumjohann, F. Benvenuto, D. Bottinelli, S. Lira, A. Uccelli, A. Lanzavecchia, B. Engelhardt, and F. Sallusto. 2009. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 10: 514-523.
34. Liu, M. T., B. P. Chen, P. Oertel, M. J. Buchmeier, D. Armstrong, T. A. Hamilton, and T. E. Lane. 2000. The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J. Immunol. 165: 2327-2330. (Pubitemid 30660672)
35. Stiles, L. N., M. T. Liu, J. A. Kane, and T. E. Lane. 2009. CXCL10 and trafficking of virus-specific T cells during coronavirus-induced demyelination. Autoimmunity 42: 484-491.
36. Greter, M., F. L. Heppner, M. P. Lemos, B. M. Odermatt, N. Goebels, T. Laufer, R. J. Noelle, and B. Becher. 2005. Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. Nat. Med. 11: 328-334. (Pubitemid 40460562)
37. Peters, N., and D. Sacks. 2006. Immune privilege in sites of chronic infection: Leishmania and regulatory T cells. Immunol. Rev. 213: 159-179. (Pubitemid 44401500)
38. Belkaid, Y., C. A. Piccirillo, S. Mendez, E. M. Shevach, and D. L. Sacks. 2002. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-507. (Pubitemid 35477041)
39. Dietze, K. K., G. Zelinskyy, K. Gibbert, S. Schimmer, S. Francois, L. Myers, T. Sparwasser, K. J. Hasenkrug, and U. Dittmer. 2011. Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points. Proc. Natl. Acad. Sci. USA 108: 2420-2425.
40. Trandem, K., D. Anghelina, J. Zhao, and S. Perlman. 2010. Regulatory T cells inhibit T cell proliferation and decrease demyelination in mice chronically infected with a coronavirus. J. Immunol. 184: 4391-4400.
41. Anghelina, D., J. Zhao, K. Trandem, and S. Perlman. 2009. Role of regulatory T cells in coronavirus-induced acute encephalitis. Virology 385: 358-367.
42. Zhao, J., J. Zhao, C. Fett, K. Trandem, E. Fleming, and S. Perlman. 2011. IFN-γand IL-10-expressing virus epitope-specific Foxp3(+) T reg cells in the central nervous system during encephalomyelitis. J. Exp. Med. 208: 1571-1577.
43. Turner, M. S., L. P. Kane, and P. A. Morel. 2009. Dominant role of antigen dose in CD4+Foxp3+ regulatory T cell induction and expansion. J. Immunol. 183: 4895-4903.
44. Goodman, W. A., A. D. Levine, J. V. Massari, H. Sugiyama, T. S. McCormick, and K. D. Cooper. 2009. IL-6 signaling in psoriasis prevents immune suppression by regulatory T cells. J. Immunol. 183: 3170-3176.
45. Goodman, W. A., A. B. Young, T. S. McCormick, K. D. Cooper, and A. D. Levine. 2011. Stat3 phosphorylation mediates resistance of primary human T cells to regulatory T cell suppression. J. Immunol. 186: 3336-3345.
46. Eriksson, K. K., L. Cervantes-Barragán, B. Ludewig, and V. Thiel. 2008. Mouse hepatitis virus liver pathology is dependent on ADP-ribose-10- phosphatase, a viral function conserved in the alpha-like supergroup. J. Virol. 82: 12325-12334.